Cargando…

Biomarkers Associated with Immune Checkpoint, N6-Methyladenosine, and Ferroptosis in Patients with Restenosis

PURPOSE: This study aimed to identify potential diagnostic markers of restenosis after stent implantation and to determine their association with immune checkpoint, ferroptosis, and N6-methyladenosine (m6A). PATIENTS AND METHODS: Microarray data were downloaded from the National Center for Biotechno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tong, Xiao, Zhao, Xinyi, Dang, Xuan, Kou, Yan, Kou, Junjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901443/ https://www.ncbi.nlm.nih.gov/pubmed/36755968 http://dx.doi.org/10.2147/JIR.S392036

Ejemplares similares

Predicting Diagnostic Gene Biomarkers Associated With Immune Checkpoints, N6-Methyladenosine, and Ferroptosis in Patients With Acute Myocardial Infarction
por: Tong, Xiao, et al.
Publicado: (2022)

circRNA, a novel diagnostic biomarker for coronary heart disease
por: Tong, Xiao, et al.
Publicado: (2023)

Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
por: Zhou, Xianyong, et al.
Publicado: (2023)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

Regulation of Antiviral Immune Response by N(6)-Methyladenosine of mRNA
por: Zhao, Baoxin, et al.
Publicado: (2021)

Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy
por: Liu, Weiwei, et al.
Publicado: (2022)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Functions and mechanisms of N6-methyladenosine in prostate cancer
por: Wan, Hongyuan, et al.
Publicado: (2022)

The N(6)-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma
por: Zhao, Rongrong, et al.
Publicado: (2021)

IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells
por: Xu, Xin, et al.
Publicado: (2022)

N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells
por: Shen, Min, et al.
Publicado: (2021)

The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma
por: Deng, Wen, et al.
Publicado: (2021)

Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

Potential roles of N6-methyladenosine (m6A) in immune cells
por: Liu, Chang, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) RNA modification in tumor immunity
por: Zheng, Siyi, et al.
Publicado: (2022)

Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1
por: Gu, Chaohui, et al.
Publicado: (2019)

Emerging Perspectives of RNA N(6)-methyladenosine (m(6)A) Modification on Immunity and Autoimmune Diseases
por: Tang, Lipeng, et al.
Publicado: (2021)

Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine
por: Xu, Yating, et al.
Publicado: (2021)

The potential role of RNA N6-methyladenosine in primary Sjögren’s syndrome
por: Xiao, Qiufeng, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
por: Zhang, He, et al.
Publicado: (2022)

Emerging role of RNA modification N6-methyladenosine in immune evasion
por: Lou, Xin, et al.
Publicado: (2021)

RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance
por: Zhao, Hua, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

N(6)-methyladenosine (m(6)A) RNA methylation signature as a predictor of stomach adenocarcinoma outcomes and its association with immune checkpoint molecules
por: Mo, Pingfan, et al.
Publicado: (2020)

Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
por: Gao, Chen, et al.
Publicado: (2022)

Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer
por: Xiao, Han, et al.
Publicado: (2021)

Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1
por: Gu, Chaohui, et al.
Publicado: (2023)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

Role of N(6)-methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
por: Ye, Tong, et al.
Publicado: (2022)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases
por: Teng, Yan, et al.
Publicado: (2023)

Regulatory role of N(6)-methyladenosine in intramuscular fat deposition in chicken
por: Zhang, Tong, et al.
Publicado: (2023)

Association of N6-methyladenosine with viruses and related diseases
por: Wu, Fang, et al.
Publicado: (2019)

Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome
por: Xiao, Qiufeng, et al.
Publicado: (2023)

The Role of N(6)-Methyladenosine (m(6)A) Methylation Modifications in Hematological Malignancies
por: Zhao, Yan, et al.
Publicado: (2022)

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
por: Ma, Mingyang, et al.
Publicado: (2022)

Mechanisms of RNA N(6)-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology
por: Lu, Jiahua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_otaju7le6q5eabpr0ihmvv0gfl